Upregulating hsa-miR-128a Increased the Effects of Pembrolizumab on Laryngeal Cancer Cells via the p53 Pathway

OBJECTIVES: Recently, immunotherapy and microRNA have shown much more promises in oncology research, inspiring new hope for a cure for various malignancies. Specifically, the function and mechanisms of action of pembrolizumab have been investigated in many cancers, but not in laryngeal squamous cell...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Hui, Guo, Yang, Huang, Jiameng, Zhou, Liang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7997759/
https://www.ncbi.nlm.nih.gov/pubmed/33791361
http://dx.doi.org/10.1155/2021/2342784

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7997759/
https://www.ncbi.nlm.nih.gov/pubmed/33791361
http://dx.doi.org/10.1155/2021/2342784

Ejemplares similares